Rasilez (aliskiren): Health Canada reviewing safety of blood-pressure drug
2011-175 December 22, 2011 For immediate release OTTAWA - In light of the recent company decision (Novartis press release) to stop a multi-national clinical trial known as the ALTITUDE study, Health Canada is informing Canadians that it is reviewing …